DMAADrugs Made In America Acquisition Corp. Ordinary Shares

10.75USD+0.28%Mkt Cap: 260.98M $P/E: 59.72

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …

Key Statistics

Company
Market Cap260.98M $
Enterprise Value361.20M $
Revenue (TTM)
Gross Profit
Net Income (TTM)5.94M $
Revenue/Share
Last Price10.75 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN
Valuation
P/E (Trailing)59.72
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B-48.97
EPS (TTM)0.18
EPS (Forward)
52W Range
10.22100% of range10.75
52W High10.75 USD
52W Low10.22 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE2.55%
ROA2.48%
Growth
Revenue Growth
Earnings Growth18.80%
Cash Flow & Leverage
Operating CF-539.19K $
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt85.11K $
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio0.03
Quick Ratio0.03
Book Value/Sh-0.2190 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.24.28M
Float29.13M
Insiders23.57%
Institutions85.95%
Short Interest
Short Ratio2.3d
Short % Float0.45%
Short % Out.0.37%
Shares Short88.66K
Short (prev mo.)82.99K
Technical
SMA 5010.67 (+0.7%)
SMA 20010.51 (+2.3%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)22.67K
Avg Vol (10d)3.59K
Technical Indicators
RSI (14)82.6
MACD0.0146
MACD Signal0.0140
MACD Hist.+0.0006
BB Upper10.73 USD
BB Middle10.71 USD
BB Lower10.69 USD
BB Width0.38%
ATR (14)0.0114 USD
Vol Ratio (20d)25.63x